Esaote to Debut New MyLabAlpha Premium Performance Portable Ultrasound System for Cardiology at the ACC.12

Share Article

Esaote announced it will introduce the MyLab®Alpha premium performance portable ultrasound system for the cardiology market at the 61st annual session of the American College of Cardiology in Chicago, March 24-27.

The MyLabAlpha is the most recent addition to the MyLab® ultrasound line and is designed around Esaote’s innovative new Productivity-Oriented Platform (POP) which delivers superior performance, ergonomics, mobility and connectivity, while maintaining the highest level of simplicity. At the core of this new platform is the exclusive e-touch feature. By simply pressing the e-touch button, users can now enter a customized environment where personal settings, complex functions, annotations and measurements can be stored and easily accessed during an examination.

“MyLabAlpha represents the next level of excellence in portable ultrasound systems,” said Claudio Bertolini, President of Esaote North America. “The ability to provide the highest level of miniaturization without compromising performance and ergonomics is the result of Esaote’s continuous investment in mobile and point-of-care solutions to meet the evolving clinicians’ needs.”

The MyLabAlpha’s advanced cardiology package delivers unparalleled performance in a portable echocardiography system. It is available in both adult and pediatric patient configurations and also can be used with transesophageal probes. The MyLabAlpha has been designed for use in multiple bedside and mobile clinical environments such as Echo Labs, ICU/CCU, Surgery, Anesthesia and Emergency Medicine. Premium features such as 2D Speckle-Tracking XStrain technology is also available for LV deformation analysis with Esaote’s latest exclusive evolution, XStrain4D*.

“XStrain 4D technology is an innovative and intuitive approach to heart function analysis,” said C. Bussadori, Cardiologist at S. Donato Hospital, Milan (Italy). “By combining common apical ultrasound views, physicians can obtain volumetric and complete assessment of left ventricle function. Global and regional curves as well as strain/strain-rate and volume measurements may be easily displayed, improving diagnostic level and confidence.”

The system offers wireless networking, full DICOM connectivity and IHE compliance. MyLab®Desk3, Esaote’s comprehensive software suite for off-line post-processing and reporting, can be accessed from any wireless device to provide added efficiency and productivity.

To learn more about the MyLabAlpha premium portable echocardiography system, visit Esaote booth (#2019) at ACC.12.

About Esaote
Esaote is internationally recognized as one of the “Top Ten” world’s leading diagnostic imaging companies, with annual revenues exceeding 330 million euros. Esaote is an award winning medical diagnostic company whose primary goal is to develop practical and affordable solutions with the highest standards of efficacy to help predict, diagnose and treat disease. Esaote markets and sells its technologies worldwide in over 80 countries. For more information, visit http://www.esaote.com.

MyLabAlpha may be not yet available for sale in all countries.
*XStrainTMTM 4D is not available for sale in the U.S. at this time.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kristen Wallpe
kwallpe@esaoteusa.com
317-813-6028
Email >
Visit website